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Introduction {#sec1}
============

At present, for metastatic tumor or unresectable lesion, chemotherapy is usually the preferred option despite the emergence of many advanced treatment technologies ([@bib19], [@bib4]). However, traditional chemotherapy, where the drug toxicity is always "ON," leads to severe systemic toxicity, including nausea, vomiting, diarrhea, kidney problems, and neuropathic pain, which often compromises patients\' quality of life ([@bib18], [@bib33], [@bib47]). Although many smart carriers have been cunningly designed to target drug delivery to tumor sites ([@bib3], [@bib35], [@bib6]), recent meta-analysis suggests that only 0.7% (median) of the administered dose is delivered to the tumor, whereas the rest is accumulated in healthy organs, which will cause some chronic diseases resulting from the toxic drugs ([@bib37], [@bib12]). Therefore, developing a therapeutic model that can be biocompatible and keep the drug inert even if the rest accumulated in healthy organs, while it exerts its therapeutic efficacy only at the tumor site via specific transformation is necessary and also highly challenging owing to the tumor inhomogeneity.

Metal ions with diverse cellular biological effects are playing more important roles in cell metabolism and proliferation than expected ([@bib9], [@bib42]). Any adjustment of ion balance may induce a series of intracellular reactions, even cell death ([@bib21]). Such a dramatic ion interference technology is expected to avoid systemic toxicity through ingenious construction. In view of this, more attention will be payed to Ca^2+^, as it is an essential component of tissues such as bone and is involved in a host of vital cell survival processes ([@bib26], [@bib5]). Calcium overload, characterized by an abnormal accumulation of free calcium ions (Ca^2+^), is a widely recognized cause of damage in numerous cell types and even of cell death ([@bib8], [@bib43]). Tumor cells are more sensitive to the persistent Ca^2+^ overload than normal cells ([@bib22], [@bib41]). In particular, transient receptor potential cation channel subfamily V member 1 (TRPV1), a nonselective cation channel that prefers Ca^2+^ over other cations, has been revealed to be highly over-expressed in many malignancies ([@bib48], [@bib40]). TRPV1 can be activated by external stimuli such as heat, low pH, capsaicin, and vanilloids ([@bib25]). Being able to manipulate TRPV1 signaling at precise times and spaces in living systems remains a challenge.

Keeping all these issues in mind, we proposed to construct a Ca^2+^ cascade via photothermal activation of the TRPV1 signaling pathways to specifically inhibit the growth of tumor with minimum systemic toxicity. In order to realize enhanced Ca^2+^ interference therapy, continuous supply of Ca^2+^ is essential. It is known that natural organisms CaCO~3~ with excellent biocompatibility and biodegradability is stable at neutral pH and can decompose in tumor acidic microenvironment, so it is mostly used as a smart carrier ([@bib7], [@bib34], [@bib44], [@bib46]). In addition, it could be used as a reservoir to keep the tumor supplied with plentiful Ca^2+^ ([@bib14], [@bib45]). Considering to activate TRPV1 signaling using near-infrared (NIR) light, we turned our attention to copper sulfide (CuS) nanoparticles (NPs) as the photothermal switch owing to the excellent photothermal efficiency ([@bib50]), photothermal combination therapy ([@bib29]), and photoacoustic (PA) imaging ([@bib51]). As shown in [Scheme 1](#sch1){ref-type="fig"}, based on enhanced permeability and retention (EPR) effect ([@bib11]), the CaCO~3~ nanocarrier could remain and decompose at tumor site to produce abundant Ca^2+^ and release photothermal CuS NPs. Irradiation of CuS NPs by NIR results in strong PA signal and local heating, which contribute to guide and open TRPV1 channels allowing an influx of Ca^2+^. After the intracellular Ca^2+^ concentration rose, much larger amounts of Ca^2+^ could accumulate in mitochondria, leading to disrupting mitochondria Ca^2+^ homeostasis and dysfunction followed by cell apoptosis. However, in normal physiological environment, CaCO~3~ was so stable that generous Ca^2+^ could not be supplied, and the absence of over-expression of TRPV1 and mild acidity stimulation ensured that Ca^2+^ interference therapy was ineffective in normal tissues. Besides, CaCO~3~ was biocompatible and degradable, which ensured the worry of systemic toxicity could be completely eliminated. More meaningfully, the intracellular Ca^2+^ cascade for specific tumor therapy may hold promise as an effective cancer therapeutic tool complementary to traditional clinical tumor treatment.Scheme 1Schematic Illustration of Calcium-Overload-Mediated Tumor Therapy by CuS\@CaCO~3~-PEG(A) The synthesis processes of CuS\@CaCO~3~-PEG.(B) The photothermal activation of the TRPV1 Ca^2+^ channels on the cell membrane.(C) The mechanism of tumor cell death induced by mitochondrial damage.

Results {#sec2}
=======

Preparation and Characterization of CuS\@CaCO~3~-PEG {#sec2.1}
----------------------------------------------------

The preparation procedure of CuS\@CaCO~3~-PEG was illustrated in [Scheme 1](#sch1){ref-type="fig"}A, and the detailed synthetic procedure was presented in the Experimental Section. Transmission electron microscopy (TEM, [Figure 1](#fig1){ref-type="fig"}A) showed the morphology of CuS, CuS\@CaCO~3~, and CuS\@CaCO~3~-PEG and as-synthesized CuS\@CaCO~3~-PEG NPs were monodispersed with an average diameter of around 100 nm. There were some morphologically spherical pellets in the CuS\@CaCO~3~, indicating that CuS was successfully loaded into CuS\@CaCO~3~. The SEM image of CuS\@CaCO~3~ was shown in [Figure S1](#mmc1){ref-type="supplementary-material"}. The corresponding size distributions were shown by dynamic light scattering in [Figure 1](#fig1){ref-type="fig"}C, in accordance with TEM results. [Figure S2](#mmc1){ref-type="supplementary-material"} further demonstrated that both CuS and CuS\@CaCO~3~ exhibited poor stability in 10% serum, whereas CuS\@CaCO~3~-PEG had better stability both in PBS and in10% serum suggesting the improvement of *in vivo* application potential. Besides, the ζ potential was reversed from 13.2 to 1.6 to −10.6 mV after loading and decorating, implying the successful encapsulation and PEGylation, which avoided nonspecific adsorption *in vivo*. The UV-visible (UV-vis) absorption spectrum of CuS\@CaCO~3~-PEG ([Figure 1](#fig1){ref-type="fig"}D) illustrated that there was a broad absorption between 700 and 1,100 nm, which was similar to the absorption of CuS NPs. X-ray diffraction results evidenced the presence of CuS NPs and CaCO~3~ in the NPs. After PEGylation, the decrease of the peak intensity was due to the cover of phospholipid bilayer on the surface ([Figure 1](#fig1){ref-type="fig"}E). To substantially confirm the successful loading of CuS NPs in CaCO~3~, energy-dispersive X-ray (EDX) mapping was conducted. As shown in [Figure 1](#fig1){ref-type="fig"}B, S and Cu elements were evenly dispersed in CuS\@CaCO~3~, which indicated that CuS was successfully encapsulated in CaCO~3~.Figure 1Characterization of the Nanoplatform(A and B) (A) TEM pictures of CuS, CuS\@CaCO~3~, and CuS\@CaCO~3~-PEG. (B) TEM elemental mapping of CuS\@CaCO~3~.(C--E) (C) Dynamic light scattering (see also [Figure S2](#mmc1){ref-type="supplementary-material"}, D) Ultraviolet-visible absorption spectrum and (E) X-ray diffraction of CuS, CuS\@CaCO~3~, and CuS\@CaCO~3~-PEG.(F) The effect of pH on release of Ca^2+^ from CuS\@CaCO~3~-PEG (inset: pictures of centrifugated CuS\@CaCO~3~-PEG at different pH for 1 h, n = 3) (see also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). Data are represented as mean ± SD.(G) Thermal images of CuS\@CaCO~3~-PEG at different pH with irradiation by 1,064-nm laser (1.2 W cm^−2^) for 10 min (see also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}).

Acid Enhanced Ca^2+^ Release and Photothermal Effect of CuS\@CaCO~3~-PEG {#sec2.2}
------------------------------------------------------------------------

Owing to the successful loading of CuS NPs in CaCO~3~, CuS\@CaCO~3~-PEG may disintegrate and release Ca^2+^ and CuS at low pH. First, the collapse of CuS\@CaCO~3~-PEG treated with different pH PBS was observed via TEM. As shown in [Figure S4](#mmc1){ref-type="supplementary-material"}, with an increase of acidity, the CuS\@CaCO~3~-PEG NPs were gradually destroyed. At pH 7.4, all of them kept intact, indicating CuS\@CaCO~3~-PEG could remain stable in physiological environments. In particular, almost all of them disintegrated into smaller particles at pH 5.0. At the same time, the light transmittance of CuS\@CaCO~3~-PEG treated with different pH was shown in [Figure 1](#fig1){ref-type="fig"}F insert, and the light transmittance gradually increased with the decrease of pH, which reveals the pH-responsive decomposition of CuS\@CaCO~3~-PEG. After centrifugation and supernatant collection, the concentrations of Ca^2+^ and Cu^2+^ were, respectively, measured via inductively coupled plasma mass spectrometry (ICP-MS). As shown in [Figure 1](#fig1){ref-type="fig"}F, after interaction for 30 min, the concentration of Ca^2+^ rose to 82 mg L^−1^ with decrease of solution pH, suggesting that the production of abundant Ca^2+^ was effective in tumor microenvironment. With disintegration of CuS\@CaCO~3~-PEG at lower pH, more CuS NPs will be released in the acid environment. As shown in [Figure S5](#mmc1){ref-type="supplementary-material"}, less than 30% of Cu^2+^ is released after 8 h of treatment at pH 7.4, suggesting the CaCO~3~ is a desired gatekeeper. On the contrary, within 1 h, the release of Cu^2+^ reached 66% and 52% at pH 5.0 and 6.5, respectively. All these results substantially demonstrated that CuS\@CaCO~3~-PEG could reactively decompose at low pH and rapidly release abundant Ca^2+^ and loaded CuS NPs.

The photothermal properties of CuS\@CaCO~3~-PEG were studied because of the influential NIR absorption band. Owing to a tumor acidic environment, we further evaluated the photothermal effect of CuS\@CaCO~3~-PEG at pH 6.5 and 5.0. As displayed in [Figure 1](#fig1){ref-type="fig"}G, the solution temperature quickly increased with prolonging of irradiation time. Notably, the lower the pH was, the faster and higher the temperature rose. It may be attributed to the release of CuS from the cracking of calcium carbonate, which had a stronger absorbance in NIR. The photothermal property of CuS\@CaCO~3~-PEG was also concentration and power dependent ([Figure S6](#mmc1){ref-type="supplementary-material"}). Besides, CuS\@CaCO~3~-PEG showed excellent thermal stability in PBS ([Figure S7](#mmc1){ref-type="supplementary-material"}).

Ca^2+^ Influx *In Vitro* by NIR-II Laser Irradiation {#sec2.3}
----------------------------------------------------

Considering that CuS\@CaCO~3~-PEG can produce abundant Ca^2+^ and has excellent photothermal conversion characteristic in tumor acidic environment, the ability of CuS\@CaCO~3~-PEG to activate heat-sensitive TRPV1 Ca^2+^ channels was examined in two different cells. The U373 glioma cells are the experimental group, which provided a high expression of TRPV1 pathway, whereas HeLa cells are the TRPV1-negative cells ([@bib16], [@bib1]). First, the intracellular Ca^2+^ influx was monitored by Ca^2+^ fluorescence probe (Fluo-4) ([Figure 2](#fig2){ref-type="fig"}A). Under laser irradiation at 1,064 nm (1.2 W cm^−2^) for 30 s, no fluorescence increase was observed in pH 7.4 + L group or pH 6.5 - L group of TRPV1-positive cells; in contrast, significant fluorescence increase was detected for S pH 6.5 + L group ([Figure 2](#fig2){ref-type="fig"}B). Therefore, Ca^2+^ influx was activated for U373 cells only when both acidic environment and NIR irradiation were satisfied, ensuring the high precision of CuS\@CaCO~3~-PEG to tumor cells. However, no fluorescence of Fluo-4 was observed in the TRPV1-negative cells (HeLa) even when the above conditions existed, validating that Ca^2+^ influx was specifically activated by PTT-induced TRPV1 opening. The quantitative fluorescence intensity of Fluo-4 was detected by flow cytometry in [Figure 2](#fig2){ref-type="fig"}C. The fluorescence intensity in U373 cells of pH 6.5 + L group was a high level when compared with the blank control group. In other groups, there was no significant fluorescence enhancement, which was consistent with the results of CLSM, showing weak fluorescence of Fluo-4. In order to further verify that heat can induce the opening of calcium channels, the two kinds of cells treated with CuS\@CaCO~3~-PEG were incubated in 43°C incubator for 10 min and the fluorescence of Fluo-4 was detected by CLSM. As shown in [Figure S8](#mmc1){ref-type="supplementary-material"}, obvious fluorescence of Fluo-4 was displayed in the mitochondria of U373 cells but not in HeLa cells. This demonstrated that it was indeed heat-induced calcium ion influx in our work.Figure 2*In Vitro* Activation of TRPV1 Ion Channels by NIR-II (1,064 nm) Laser Irradiation(A) Schematic illustration of photothermal mechanism of activation of TRPV-1 Ca^2+^ channels in cells. The intracellular concentration of Ca^2+^ was monitored in real time by using Fluo-4 as the indicator, which turned on its fluorescence upon binding with Ca^2+^.(B) CLSM images and colocation ratio analysis of biodistribution of Ca^2+^ released from CuS\@CaCO~3~-PEG in mitochondria after treatment with CuS\@CaCO~3~-PEG in U373 and HeLa cells after 1,064-nm laser irradiation (1.2 W cm^−2^) (see also [Figure S8](#mmc1){ref-type="supplementary-material"}); scale bar: 10 μm.(C--E) (C) Quantitative determination of intracellular (U373 and HeLa cells) Ca^2+^ by flow cytometry. The cytotoxicity of CuS\@CaCO~3~-PEG against U373 (D) and HeLa (E) cells in the presence or absence of 1,064-nm laser irradiation (see also [Figures S9--S12](#mmc1){ref-type="supplementary-material"}). ∗∗∗p \< 0.001, compared with the control group. Data are represented as mean ± SD.

When intracellular Ca^2+^ concentrations rise, rapid mitochondrial Ca^2+^ uptake in living cells was shown ([@bib30]). Because when temporary imbalance of intracellular Ca^2+^ occurs, mitochondria as sensors and regulators will take in Ca^2+^ from the cytoplasm to regulate intracellular calcium homeostasis ([@bib24]). Inspired by this, the colocalization of intracellular Ca^2+^ and mitochondria was then observed through CLSM, where mitochondria were marked by MitoRed indicator. Most of Ca^2+^ was well co-localized with mitochondria, which revealed that abundant Ca^2+^ finally arrived at mitochondria after flowing into the cells through TRPV1 channels.

Selective Toxic Activation of CuS\@CaCO~3~-PEG {#sec2.4}
----------------------------------------------

Mitochondria regulate intracellular calcium homeostasis ([@bib38]); however, excessive Ca^2+^ in mitochondria triggers cell apoptosis ([@bib10]). The calcium overload toxicity assays of CuS\@CaCO~3~-PEG were executed for U373 cells and HeLa cells. As shown in [Figure 2](#fig2){ref-type="fig"}D, CuS\@CaCO~3~-PEG would not initiate U373 cells death at pH 7.4 with/without light irradiation, and even when the concentration of Ca^2+^ was increased without light irradiation ([Figure S9](#mmc1){ref-type="supplementary-material"}), suggesting the good biocompatibility of CuS\@CaCO~3~-PEG under typical physiological pH environment. To evaluate the selective toxicity of CuS\@CaCO~3~-PEG, the toxicities of CuS\@CaCO~3~-PEG on normal cells (COS7 cells) and TRPV1-positive tumor cell lines (HEK293 cells) ([@bib27]) were tested by MTT. As shown in [Figure S10](#mmc1){ref-type="supplementary-material"}, the CuS\@CaCO~3~-PEG had no toxicity to normal cells, whereas it had obvious toxicity to TRPV1-positive cells (HEK 293 cells), which further confirmed the nanoplatform for specifically inhibiting cancer. When cells were cultured at pH 6.5 without irradiation, cells exhibited good survival, implying that the Ca^2+^ influx induced by endocytosis was not enough to induce cell death maybe due to its own mechanism of calcium regulation. Meanwhile, CuS exhibited little phototoxicity in the cell experiment, because the temperature of culture medium was strictly detected and controlled at around 43°C by thermal camera ([Figure S11](#mmc1){ref-type="supplementary-material"}), in order to avoid the cell death caused by hyperthermia. In sharp contrast, CuS\@CaCO~3~-PEG displayed apparent toxicity in U373 cells at pH 6.5 with laser irradiation. Combined with the results of Ca^2+^ influx and MTT, it was proved that Ca^2+^ overload in mitochondria could finally lead to cell death. However, there existed no toxicity in HeLa cell experiments ([Figure 2](#fig2){ref-type="fig"}E), which powerfully confirmed that selective cancer cell death caused by calcium overload was indeed guided by activation of TRPV1. In addition, the two kinds of cells treated with CuS\@CaCO~3~-PEG were cultured in 43°C incubator for 10 min, and the same phenomenon of cell viability appeared. There existed obvious toxicity only in pH 6.5 group of U373 cells ([Figure S12](#mmc1){ref-type="supplementary-material"}). All these results substantially indicated that CuS\@CaCO~3~-PEG could selectively kill U373 cells (TRPV1+), because the opening of TRPV1 channels by heat was the fuse of calcium overload, which led to subsequent cell death.

To investigate the cell death pathway by calcium overload, cells were incubated with CuS\@CaCO~3~-PEG in the presence or absence of light irradiation under different pH environment, and then cells were labeled with annexin VFITC/PI. Early apoptosis can be detected using annexin V by combining with the exposed phosphatidylserine on the cell surface, whereas PI can stain nuclear chromatin rapidly in membrane-compromised cells during late apoptosis or necrosis ([@bib15]). As shown in [Figure S13](#mmc1){ref-type="supplementary-material"}, cells treated with CuS\@CaCO~3~-PEG at pH 6.5 with light irradiation exhibited the highest late apoptotic and the necrosis ratio of 20.17% compared with other groups. This was in good agreement with the published report that disruption of intracellular Ca^2+^ homeostasis will result in an increased rate of cell necrosis ([@bib20], [@bib28]).

Disruption of Mitochondrial Ca^2+^ Homeostasis of CuS\@CaCO~3~-PEG {#sec2.5}
------------------------------------------------------------------

Proposed apoptosis mechanism induced by CuS\@CaCO~3~-PEG was illustrated in [Figure 3](#fig3){ref-type="fig"}A. For further investigating the mechanism of apoptosis of calcium overload in mitochondria, mitochondrial dysfunction resulting from disruption of mitochondrial Ca^2+^ homeostasis was studied by tetramethyl rhodamine dye (TMRM) staining, because the decrease in fluorescence of TMRM reflects an increase in the degree of depolarization of the membrane potential ([@bib17]). As shown in [Figure 3](#fig3){ref-type="fig"}B, there was bright red fluorescence of TMRM when U373 cells treated with CuS\@CaCO~3~-PEG were at pH 7.4 with light irradiation, suggesting that a little Ca^2+^ flowing through TRPV1 channels would not damage the mitochondria. When U373 cells treated with CuS\@CaCO~3~-PEG were at pH 6.5 without light irradiation, the fluorescence changed little, indicating that the cell itself could maintain Ca^2+^ homeostasis and protect mitochondria, unless a specific regulating pathway was destroyed ([@bib23]). However, in pH 6.5 + L group of U373 cells, the red fluorescence dramatically decreased. This great difference suggested that Ca^2+^ overload in mitochondria by opening the TRPV1 channels seriously harassed the membrane potential of mitochondria in U373 cells (TRPV1+). In contrast, there was no difference in fluorescence intensity between pH 6.5 with and without light in HeLa cells. Simultaneously, the quantitative results of fluorescence intensity were further determined via flow cytometry in [Figure S14](#mmc1){ref-type="supplementary-material"}. When compared with other groups, significant decrease of the fluorescence intensity of TMRM was observed in pH 6.5 + L group of U373 cells, in accordance with CLSM results. Once the mitochondria were damaged, there was the influx of various regulatory proteins including cytochrome *c* (Cyt *c*) and caspase-3 proteins into the cytoplasm ([@bib13]) and the decrease of antiapoptotic protein Bcl-2 ([@bib31]). To confirm this, the applications of western blotting (WB) techniques were executed to study the expression of these proteins. As shown in [Figure 3](#fig3){ref-type="fig"}C, the protein levels of caspase-3 and cytochrome *c* were elevated when U373 cells treated by CuS\@CaCO~3~-PEG were at pH 6.5 with light irradiation, whereas the protein levels in other groups were reduced. Besides, only when U373 cells were treated by CuS\@CaCO~3~-PEG in pH 6.5 + L group, the expressions of Bcl-2 protein were significantly down-regulated. Detailed quantitative results of WB were gathered in [Figure S15](#mmc1){ref-type="supplementary-material"}. Because mitochondria are the energy house, the damage of mitochondrial function might directly affect the production of ATP ([@bib49]). As shown in [Figure 3](#fig3){ref-type="fig"}D, the ATP content of U373 cells in 6.5 + L group decreased significantly compared with that of other groups, indicating that Ca^2+^ overload in mitochondria would damage the energy supply of cancer cells. All of the results revealed that mitochondrial-mediated apoptotic pathway was activated, after the mitochondrial calcium ion was overloaded.Figure 3The Mechanism of Mitochondrial Damage Mediated by Calcium Overload *In Vitro*(A) Schematic illustration of proposed apoptosis mechanism induced by CuS\@CaCO~3~-PEG.(B) Membrane depolarization of mitochondria when U373 and HeLa cells were treated with CuS\@CaCO~3~-PEG under different pH in the presence or absence of light irradiation. Mitochondria were labeled with TMRM (see also [Figure S14](#mmc1){ref-type="supplementary-material"}); scale bar: 50 μm.(C) Western blotting analysis of caspase-3, Cyt *c*, and Bcl-2 (see also [Figure S15](#mmc1){ref-type="supplementary-material"}).(D) Intracellular (U373 and HeLa cells) ATP content analysis under the same environment above (n = 3). Data are represented as mean ± SD.

Multimodal Imaging of Tumor {#sec2.6}
---------------------------

The therapeutic capability *in vivo* of CuS\@CaCO~3~-PEG NPs was evaluated on HepG2 (liver hepatocellular cells) xenograft tumor mouse models, but not on the U373 tumor-bearing mouse models, since U373 cells grew too slowly, which made it challenging to establish tumor-bearing mouse models, whereas HepG2 tumor-bearing mouse models were easy to establish and also possessed high expression of TRPV1 pathway ([@bib36], [@bib32], [@bib2]). Also, liver cancer is one of the most common and lethal cancers in the human digestive system. Prior to *in vivo* therapy, the biodistribution of the nanomedicine was tracked by Cy7 via fluorescence imaging *in vivo*. As shown in [Figure 4](#fig4){ref-type="fig"}A, the fluorescence gradually appeared in the tumor site over time. After 4 h of injection, more fluorescence signal of Cy7 was observed in the tumor than at other time points, so in the following *in vivo* antitumor activity studies, the NIR laser irradiation time was set at 4 h after injection. At 24 h post injection of Cy7-labeled CuS\@CaCO~3~-PEG, mice were killed and their tumors and organs were exfoliated for ex *vivo* imaging. As shown in [Figure 4](#fig4){ref-type="fig"}, except for the liver, tumor had the most robust fluorescence, since liver is the main metabolic organ, leading to the nonspecific liver uptake. The biodistribution of Cy7-labeled CuS\@CaCO~3~-PEG revealed that CuS\@CaCO~3~-PEG could significantly accumulate in the tumor site via enhanced penetration and retention effect. Furthermore, the photoacoustic imaging of CuS\@CaCO~3~-PEG was explored *in vitro* and *in vivo*. First, the linear relationship between the concentrations and the mean photoacoustic signals (R^2^ = 0.985) was shown in [Figure 4](#fig4){ref-type="fig"}C, which indicated that the CuS\@CaCO~3~-PEG was an effective photoacoustic contrast agent for diagnosis. Thus, the *in viv*o PAI performance of CuS\@CaCO~3~-PEG was further evaluated compared with CuS in HepG2 tumor-bearing BALB/c mice. The 3D high-resolution PAI of the whole mice were recorded in a time-dependent method after intravenous injection ([Figures 4](#fig4){ref-type="fig"}D and 4E). In the free CuS group, after injection of CuS for 1 h, the PA signal was little in the tumor, whereas the partial signal was in the tumor and kidney at 4 h, indicating that CuS NPs were cleared by the body after injection for 4 h. After injection for 24 h, there were few fluorescence signals in the tumor. Meanwhile, in the CuS\@CaCO~3~-PEG group, after injection for 1 h, the PA signal of CuS\@CaCO~3~-PEG was stronger compared with that of free CuS, whereas an obvious PA signal occurred in the tumor site at 4 h, and still was at a high level in tumor at 24 h. Comparisons showed that CuS\@CaCO~3~-PEG had better tumor accumulation and 3D diagnosis than small size CuS in the blood circulation, which would contribute to the subsequent Ca^2+^-mediated therapy guided by 3D PA diagnosis.Figure 4*In Vivo* Fluorescence and Three-Dimensional PA Imaging(A) Biodistribution images of Cy7-loaded CuS\@CaCO~3~-PEG nanoparticles in HepG2 tumor-bearing mice at preset times after intravenous injection. The black circles pointed the tumor tissue.(B) *Ex vivo* fluorescence images of various organs and tumor tissue at 24 h after injection.(C) *In vitro* PA imaging of different concentrations of CuS\@CaCO~3~-PEG under 1,064-nm laser irradiation. Data are represented as mean ± SD.(D) *In vivo* three-dimensional PA imaging of the tumor-bearing mice intravenous injection with CuS\@CaCO~3~-PEG and CuS under 1,064-nm laser irradiation at different times. The white circles pointed the tumor tissue. Scale bar: 6 mm.(E) The amplified PA imaging pictures of the local tumors in [Figure 4](#fig4){ref-type="fig"}D. Scale bar: 1 mm.

Ca^2+^-Mediated Tumor Therapy *In Vivo* {#sec2.7}
---------------------------------------

Subsequently, the *in vivo* Ca^2+^-interference therapy was conducted, as shown in [Figure 5](#fig5){ref-type="fig"}A. The HepG2 tumor-bearing female BALB/c nude mice were randomly divided into six groups for the different treatments: (1) PBS, (2) CuS +1,064 nm light irradiation, (3) CaCO~3~-PEG + 1,064 nm light irradiation, (4) CuS\@CaCO~3~-PEG, (5) CuS\@CaCO~3~-PEG + 1,064 nm light irradiation, and (6) CuS\@CaCO~3~-PEG 43°C. After 4 h injection, the irradiation was performed, and the laser irradiation time was controlled to be 10 min in an intermittent manner (30 s break after 30 s of irradiation) so that the temperature of tumor areas was controlled below 43°C by FLIR infrared camera ([Figure 5](#fig5){ref-type="fig"}B), which was favorable to open the TRPV1 channels while avoiding the burn of tumors by hyperthermia. As shown in [Figure 5](#fig5){ref-type="fig"}C, evident inhibition of tumors was observed in group 5 (CuS\@CaCO~3~-PEG with light exposure) and group 6 (CuS\@CaCO~3~-PEG 43°C). However, there was no therapeutic effect in other groups compared with the PBS group. During treatment, there was no change in body weight in the six groups ([Figure S16](#mmc1){ref-type="supplementary-material"}A), suggesting the negligible side effect. After 10 days treatment, it was found that the harvested tumor displayed the lowest values in size and weight in group 5 and group 6 than those in the other groups ([Figures 5](#fig5){ref-type="fig"}D and [S16](#mmc1){ref-type="supplementary-material"}B), suggesting that the nanoplatform had specific therapeutic effect *in vivo*. The blood circulation half-lives of CuS\@CaCO~3~-PEG (3.0 h) could reach about 2-fold that of CuS\@CaCO~3~ (1.6 h) and 4-fold that of the bare CuS (0.8 h) by ICP-MS in [Figure S17](#mmc1){ref-type="supplementary-material"}, revealing that CuS\@CaCO~3~-PEG exhibited enhanced blood circulation after PEGylation *in vivo*. To check whether a large amount of Ca^2+^ accumulated in the tumors, organs and tumors of mice in those groups were collected, digested, and then examined by ICP-MS. As shown in [Figure 5](#fig5){ref-type="fig"}E, it could be found that, after treatment by CuS\@CaCO~3~-PEG with light irradiation, the Ca^2+^ content in tumors significantly increased compared with that of the control groups, confirming abundant Ca^2+^ production and retention in tumors from CuS\@CaCO~3~-PEG after light irradiation. Yet, Ca^2+^ in the control groups were mainly concentrated in spleen, lung, and kidney, since these are the main metabolic organs ([@bib39]). The desired therapeutic effects were also confirmed by physiological pathological staining in [Figure 5](#fig5){ref-type="fig"}F. For H&E staining, a small portion of purple-blue (normal nucleus) and large amounts of deformed nuclei (karyopyknosis, separation, and fragmentation) in tumor tissues were observed in the CuS\@CaCO~3~-PEG + Laser and CuS\@CaCO~3~-PEG 43°C groups. From the TUNEL staining, representative apoptosis-positive cells were marked by green nuclei in the last two groups. Simultaneously, there were large numbers apoptotic cells in caspase-3 staining assay. On the contrary, there were no significant physiological morphology changes in the staining of tumor tissue sections in other groups as compared with results in PBS group. Altogether, the photothermally induced opening of TRPV1 channels led to the overload of Ca^2+^ in tumor, which effectively realized Ca^2+^-interference therapy and damaging against tumor survival *in vivo*.Figure 5*In Vivo* Calcium-Overload-Mediated Tumor Therapy(A) Schematic illustration of CuS\@CaCO~3~-PEG-based photothermal activation of calcium influx inhibits tumor growth.(B) IR thermal images of tumor-bearing mice under 1,064-nm laser irradiation to control temperature after systemic administration of CaCO~3~-PEG, CuS, and CuS\@CaCO~3~-PEG at post-injection time of 4 h.(C and D) (C) Tumor volume change and (D) photos of the tumors extracted from mice in different groups after treatment (see also [Figure S16](#mmc1){ref-type="supplementary-material"}).(E) Biodistribution of Ca^2+^ content in various organs and tumor after 1,064-nm laser irradiation (1.2 W cm^−2^) for 10 min at 4 h intravenous injection of CuS\@CaCO~3~-PEG, the Ca^2+^ content was detected by ICP-MS.(F) H&E, TUNEL, and cleaved caspase-3 staining of tumor tissues exfoliated from different groups. Scale bar: 50 μm. ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001, compared with the indicated group. Data are represented as mean ± SD.

Neglectable systemic toxicity should also be taken into account when effective cancer treatment was carried out. So, the minimal systemic toxicity had also been demonstrated to analyze the physiological pathology of major organs by H&E staining. Compared with the results of PBS, there were no physiological morphology changes in heart, liver, spleen, lung, and kidney in [Figure 6](#fig6){ref-type="fig"}A, suggesting biosafety of the nanoplatform *in vivo*. In addition, potential toxicity had been studied through liver function markers glutamic pyruvate transaminase (ALT) and aspartate aminotransferase (AST) and kidney function markers blood urea nitrogen (BUN) and creatinine (CR) in serum in [Figure 6](#fig6){ref-type="fig"}B. These results suggested that there were no dysfunctions of liver and kidney in the treatment of CuS\@CaCO~3~-PEG *in vivo*. Thus, it can be concluded that the Ca^2+^-interference therapy induced by photothermal activation of a TRPV1 signaling pathway to specifically inhibit tumor had negligible biotoxicity, owing to its excellent biocompatibility and biodegradability. More importantly, there were no toxic drugs in the whole treatment, which may cause the worry of systemic toxicity.Figure 6Systemic Toxicity Evaluation of the Nanoplatform(A) H&E staining of lung, liver, spleen, heart, and kidneys exfoliated from different groups. "L" represents that the 1,064-nm laser irradiation was to maintain the temperature of tumor at about 43°C for 10 min. Scale bar: 50 μm.(B) ALT, AST, BUN, and CR in serum were detected in various samples. Data are represented as mean ± SD.

Discussion {#sec3}
==========

We developed an intracellular Ca^2+^ cascade that can be induced by photothermal activation of a TRPV1 signaling pathway to specifically inhibit tumor without any worry of systemic toxicity. CuS\@CaCO~3~-PEG could specifically construct Ca^2+^ cascades in the presence of the overexpress TRPV1 channels and NIR-II light irradiation at tumor sites. Subsequently, the overflowing Ca^2+^ caused disruption of mitochondrial Ca^2+^ homeostasis and dysfunction, leading to efficient tumor inhibition. In addition, released photothermal CuS NPs could be used as an enhanced photoacoustic (PA) imaging agent simultaneously to provide instant diagnostic functions. More importantly, the Ca^2+^-interference therapy demonstrated here avoided the obstacles of cancer treatments, i.e., premature drug leakage, off-targeting, and poor biocompatibility, which lightens the availability of other metal ions in oncotherapy and opens a new door for further higher-quality clinical cancer treatment.

Limitations of the Study {#sec3.1}
------------------------

Even though we performed a Ca^2+^ cascade by NIR-II photothermal switch for specific tumor therapy *in vitro* and *in vivo*, we did not study the threshold of Ca^2+^ concentration in Ca^2+^-interference therapy. Single calcium overload showed obvious antitumor effect; whether the nanoplatform combined with other treatments possessing the desired effect of "1 + 1 \> 2" needs further investigation.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods and Figures S1--S17
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